Safety of Ultrasonic Enhancing Agents in Patients with COVID-19
- 15 May 2020
- journal article
- letter
- Published by Elsevier BV in Journal of the American Society of Echocardiography
- Vol. 33 (7), 906-908
- https://doi.org/10.1016/j.echo.2020.04.022
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of CardiologyJournal of the American Society of Echocardiography, 2020
- COVID-19 and Cardiovascular DiseaseCirculation, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Transthoracic cardiac ultrasound in prone position: a technique variation descriptionIntensive Care Medicine, 2018
- Safety With Echocardiographic Contrast AgentsCirculation: Cardiovascular Imaging, 2017
- Transesophageal echocardiography in prone position during severe acute respiratory distress syndromeIntensive Care Medicine, 2011
- Impact of Contrast Echocardiography on Evaluation of Ventricular Function and Clinical Management in a Large Prospective CohortJournal of the American College of Cardiology, 2009